-
R129875-1gRasagiline Mesylate is a new MAO-B inhibitor for the treatment of idiopathic Parkinson's disease.A selective irreversible MAO-B inhibitor
-
R129875-250mgRasagiline Mesylate is a new MAO-B inhibitor for the treatment of idiopathic Parkinson's disease.A selective irreversible MAO-B inhibitor
-
R129875-50mgRasagiline Mesylate is a new MAO-B inhibitor for the treatment of idiopathic Parkinson's disease.A selective irreversible MAO-B inhibitor
-
R129875-5gRasagiline Mesylate is a new MAO-B inhibitor for the treatment of idiopathic Parkinson's disease.A selective irreversible MAO-B inhibitor
-
R131891-100mgToll-like receptor 7 (TLR7) agonist
-
R131891-1gToll-like receptor 7 (TLR7) agonist
-
R131891-200mgToll-like receptor 7 (TLR7) agonist
-
R131891-250mgToll-like receptor 7 (TLR7) agonist
-
R131891-50mgToll-like receptor 7 (TLR7) agonist
-
R131891-5gToll-like receptor 7 (TLR7) agonist
-
R341349-100mgRoflumilast N-Oxide
-
R341349-1mgRoflumilast N-Oxide